Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Dow
Colorcon
Merck
AstraZeneca

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Chlorogenic Acid

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Chlorogenic Acid?

Chlorogenic Acid is an investigational drug.

There have been 7 clinical trials for Chlorogenic Acid. The most recent clinical trial was a Phase 2 trial, which was initiated on November 27th 2018.

The most common disease conditions in clinical trials are Neoplasms, Lung Neoplasms, and Keratosis. The leading clinical trial sponsors are Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, and Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

There is one US patent protecting this investigational drug and ten international patents.

Recent Clinical Trials for Chlorogenic Acid
TitleSponsorPhase
Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM PatientsSichuan J.Z. Bio-chemical Science and Technology Development Co., LtdPhase 2/Phase 3
Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung CancerCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 1/Phase 2
Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung CancerSichuan J.Z. Bio-chemical Science and Technology Development Co., LtdPhase 1/Phase 2

See all Chlorogenic Acid clinical trials

Clinical Trial Summary for Chlorogenic Acid

Top disease conditions for Chlorogenic Acid
Top clinical trial sponsors for Chlorogenic Acid

See all Chlorogenic Acid clinical trials

US Patents for Chlorogenic Acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Chlorogenic Acid   Start Trial Granulation of a stevia sweetener PureCircle Sdn Bhd (Kuala Lumpur, MY)   Start Trial
Chlorogenic Acid   Start Trial Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   Start Trial
Chlorogenic Acid   Start Trial Uses of chlorogenic acid in the preparation of medicaments for treatment of oligodendroglioma SICHUAN JIUZHANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD. (Chengdu, Sichuan, CN)   Start Trial
Chlorogenic Acid   Start Trial Hair dyeing process using at least one ortho-diphenol and one organic salt of titanium and of a carboxylic acid L'OREAL (Paris, FR)   Start Trial
Chlorogenic Acid   Start Trial Matrix and layer compositions for protection of bioactives Novus International, Inc. (St. Charles, MO)   Start Trial
Chlorogenic Acid   Start Trial Method for regulating retinal endothelial cell viability The University of Tennessee Research Foundation (Memphis, TN)   Start Trial
Chlorogenic Acid   Start Trial Nutritional composition for promoting gut microbiota balance and health Nestec S.A. (Vevey, CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Chlorogenic Acid

Drugname Country Document Number Estimated Expiration Related US Patent
Chlorogenic Acid Brazil 112012011382 2029-11-12   Start Trial
Chlorogenic Acid Canada 2780561 2029-11-12   Start Trial
Chlorogenic Acid European Patent Office 2498625 2029-11-12   Start Trial
Chlorogenic Acid European Patent Office 3461342 2029-11-12   Start Trial
Chlorogenic Acid Spain 2707280 2029-11-12   Start Trial
Chlorogenic Acid Mexico 2012005608 2029-11-12   Start Trial
Chlorogenic Acid Mexico 353094 2029-11-12   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Mallinckrodt
Moodys
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.